Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
262
-
Total 13F shares, excl. options
-
71.1M
-
Shares change
-
-17.4M
-
Total reported value, excl. options
-
$971M
-
Value change
-
-$283M
-
Put/Call ratio
-
0.2
-
Number of buys
-
97
-
Number of sells
-
-142
-
Price
-
$13.63
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2021
333 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2021.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 262 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.1M shares
.
Largest 10 shareholders include ARK Investment Management LLC (7.86M shares), CITIGROUP INC (7.79M shares), BSN Capital Partners Ltd (4.68M shares), Mondrian Investment Partners LTD (4.06M shares), MACQUARIE GROUP LTD (3.74M shares), GOLDMAN SACHS GROUP INC (3.73M shares), Parametric Portfolio Associates LLC (3.4M shares), NORTHERN TRUST CORP (2.34M shares), BlackRock Inc. (2.18M shares), and FMR LLC (1.92M shares).
This table shows the top 262 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.